Back to Trials
NCT07349810PHASE4Recruiting

Post Operative Infusion Pump Pain Study

Rutgers, The State University of New Jersey

Start Date

1/1/2026

Completion Date

12/31/2026

Summary

This study will be a pragmatic, prospective cluster randomized trial, where clusters will formed based on sequential 2 week time increments across the study recruitment period.. Patients 18 years or older undergoing ACL reconstruction, open shoulder labrum or rotator cuff surgery, arthroscopic rotator cuff repair, proximal or distal patellar realignment surgery, open knee arthrotomy cases (i.e. inside out meniscus repair, osteochondral allograft transplantation (OCA), meniscal allograft transplantation (MAT)) at University Center for Ambulatory Surgery, LLC (UOA) will be reviewed for eligibility. Once identified, potential study subjects will be asked whether they are interested in participating in the project. If the patient agrees, the subject will be given the informed consent to read and sign. Objectives: The primary objective is to compare the effectiveness of postoperative infusion pain pump versus preoperative nerve block in reducing visual analog pain scores/numerical pain rating scale (VAS/NPRS) in the postoperative period. The second objective is to evaluate the requirement of narcotic and non-narcotic analgesic medications between the two groups. Hypotheses: Use of continuous infusion pain pump or single shot peripheral block will result in similar post-operative pain control after outpatient sports medicine surgical cases.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Age 18 years or older * ACL reconstruction * Open shoulder labrum or rotator cuff surgery * Arthroscopic rotator cuff repair * Proximal or distal patellar realignment surgery * Open knee arthrotomy cases - Inside out meniscus repair, OCA, MAT Exclusion Criteria: * Age under 18 years * Body mass index of greater than 40 kg/m2 * American Society of Anesthesiologist class 4 physical status or greater * History of drug or alcohol abuse * Chronic opioid use/pain management doctor * Allergy to bupivacaine, ropivacaine or pharmacologic analogs * Any coagulation disorders * Existing nerve injury * Severe bronchopulmonary disease * Pregnant patients

Interventions

DRUG

Bupivacaine 0.5% Injectable Solution

DRUG

Ropivacaine 0.2% Injectable Solution

DRUG

1.3% liposomal bupivacaine (Exparel)

DEVICE

ambIT Infusion Pump

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Post Operative Pain

Locations

University Center for Ambulatory Surgery

Somerset, New Jersey 08873

United States